Second Quarter Revenue Up For Medtrade Exhibitor ResMed
ResMed revenue for the quarter ended Dec. 31, 2024 increased 10% to $1.3 billion; up 10%.
CPAP Payment Prohibition
The purpose is to ensure that the CPAP device is medically necessary by preventing the CPAP supplier’s financial interest from creeping into the diagnosis and treatment.
Revenue Up At Medtrade Exhibitor ResMed
Results for the first quarter of fiscal year 2025 at ResMed are in with revenue up by 11% to $1.2 billion.
ResMed Debuts Its First Fabric CPAP Mask
Medtrade exhibitor ResMed has launched its AirTouch™ N30i mask, designed to create a natural and comfortable sleep experience for users.
Encore Healthcare Partners With Trace Medical
Together they launched Vent360+, a solution to streamline the provision of ventilator services for HME providers.
End Users Join Efforts To Address NIV And CGM Access Issues
AAHomecare launched two portals to collect end user and family caregiver stories about the real-world impact of policy changes for NIV and continuous glucose monitors (CGM).